Eisai Launches New OTC Antituissive Expectorant ASTHPHYLLIN S Tablets.Tokyo, Japan, Aug 23, 2005 - (JCNN JCNN Japan Corporate News Network ) - Eisai announced on August 22 that it began marketing ASTHPHYLLIN S, an over-the-counter expectorant expectorant /ex·pec·to·rant/ (ek-spek´ter-ant) 1. promoting expectoration. 2. an agent that promotes expectoration. drug, on the same day. Based on ASTHPHYLLIN, the company's proprietary ethical drug indicated for asthma, the new product contains diprophylline, dl-methylephedrine hydrochloride, noscapine, and diphenhydramine hydrochloride, and helps alleviate coughing and loosen phlegm phlegm humor effecting temperament of sluggishness. [Medieval Physiology: Hall, 130] See : Laziness . The drug comes in two sizes, 60- and 120-tablet bottles, which retail for 1,344 yen ($12) and 2,394 yen ($21), respectively. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion